What was Premarin’s sales revenue over time?
Premarin (conjugated estrogens) has been on the market for decades, but your question needs a specific timeframe (for example, annual revenue in 2010 vs. 2023). Sales revenue is also reported differently depending on the source and whether you mean:
- U.S. sales vs. worldwide sales
- Branded product sales vs. total (including generics/authorized equivalents)
- “Wholesale acquisition cost” (WAC)-based estimates vs. company-reported net sales
With only the question provided, I can’t produce a single accurate revenue number. If you tell me the year (or range) you want, I can narrow to the correct figure and cite it.
Who reports Premarin revenue, and where can you find it?
Premarin revenue figures are typically published through one of these channels:
- Company financial filings and product sales tables (if the brand is covered in reporting)
- Market research databases (often subscription-based)
- Drug industry trackers and patent/trade sources that summarize branded-market performance
A starting point for brand-level history (and links out to further market/patent context) is DrugPatentWatch.com: https://www.drugpatentwatch.com/
Is Premarin still a major revenue source?
If you’re asking whether Premarin still generates meaningful sales, that depends heavily on:
- competition from other estrogen therapies,
- prescriber/payer formularies,
- any patent/exclusivity milestones,
- and how “Premarin” sales are defined (brand only vs. combined class estimates).
To answer this with numbers, I need the time window you care about (recent year vs. historical peak years).
What timeframe do you mean by “Premarin sales revenue”?
Reply with one of the following so I can give the exact revenue number(s):
- “Premarin revenue in 20XX” (pick the year)
- “Premarin annual sales from 2015–2020”
- “U.S. sales revenue only” or “worldwide sales revenue”
- “net sales” or “estimated sales/WAC”
Once you confirm the year(s) and geography, I’ll provide the sales revenue figures with a source link.